The AHEAD clinical trial will assess whether a new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. The Glenn Biggs Institute for…

(PRWeb December 02, 2022)

Read the full story at https://www.prweb.com/releases/can_alzheimers_disease_be_delayed_or_stopped_before_the_symptoms_begin_a_new_clinical_trial_strives_to_find_answers/prweb19053084.htm